No Prescription |
 |
 | ||
|
Actonel Generic Risedronate Sodium |
|
| ||
No Prescription » Prescription Drugs 1 » Actonel Generic Risedronate Sodium Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: ACTONEL is indicated for the treatment and prevention of osteoporosis in postmenopausal women. Risedronate is used to prevent and treat certain types of bone loss (osteoporosis). Osteoporosis causes bones to become thinner and break (fracture) more easily. Your chance of developing osteoporosis increases as you age after menopause or if you are taking corticosteroid medications (e.g. prednisone) for long periods of time. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of fractures. Risedronate belongs to a class of medications called bisphosphonates. How to use Actonel OralRead the Patient Information Leaflet provided by your pharmacist before you start using risedronate and each time you get a refill. Follow the instructions very closely to maximize the amount of drug absorbed and reduce the risk of injury to your esophagus. Consult your doctor or pharmacist if you have any questions. Take this medication by mouth usually once a day or as directed by your doctor. Take it after getting up for the day and before taking your first food beverage or other medication. Do not take it at bedtime or while you are still in bed. Take this medication with a full glass (6-8 ounces or 180-240 milliliters) of plain water. Do not take it with any other beverage. Swallow the tablet whole. Do not chew or suck on it. Then stay fully upright (sitting standing or walking) for at least 30 minutes and do not lie down until after your first food of the day. Wait at least 30 minutes after taking risedronate before you eat or drink anything other than plain water and before taking any other medication by mouth. Calcium or iron supplements vitamins with minerals antacids containing calcium/magnesium/aluminum dairy products (e.g. milk yogurt) and calcium-enriched juice may interfere with absorption of risedronate. Medications such as quinapril certain forms of didanosine (chewable/dispersible buffered tablets or pediatric oral solution) sucralfate and bismuth subsalicylate may also interfere with absorption. Do not take these products for at least 30 minutes after taking risedronate. Use this medication regularly in order to get the most benefit from it. Remember to take it at the same time each morning. Buy Actonel Generic Risedronate Sodium and other Prescription Drugs 1 products online at Medstore. 3628
About Actonel Generic Risedronate Sodium: Product Type: Prescription Drugs 1 Actonel (Generic Risedronate Sodium) Actonel (Generic Risedronate Sodium) Generic Risedronate Sodium 5mg 28 Tablets Generic Risedronate Sodium Actonel
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
